Shanghai GenTech Co Ltd (688596) - Net Assets

Latest as of September 2025: CN¥3.92 Billion CNY ≈ $574.19 Million USD

Based on the latest financial reports, Shanghai GenTech Co Ltd (688596) has net assets worth CN¥3.92 Billion CNY (≈ $574.19 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥12.58 Billion ≈ $1.84 Billion USD) and total liabilities (CN¥8.65 Billion ≈ $1.27 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shanghai GenTech Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥3.92 Billion
% of Total Assets 31.19%
Annual Growth Rate 25.63%
5-Year Change 107.31%
10-Year Change 923.6%
Growth Volatility 43.52

Shanghai GenTech Co Ltd - Net Assets Trend (2013–2024)

This chart illustrates how Shanghai GenTech Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Shanghai GenTech Co Ltd asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Shanghai GenTech Co Ltd (2013–2024)

The table below shows the annual net assets of Shanghai GenTech Co Ltd from 2013 to 2024. For live valuation and market cap data, see market value of Shanghai GenTech Co Ltd.

Year Net Assets Change
2024-12-31 CN¥3.53 Billion
≈ $517.17 Million
+15.71%
2023-12-31 CN¥3.05 Billion
≈ $446.97 Million
+26.58%
2022-12-31 CN¥2.41 Billion
≈ $353.11 Million
+29.24%
2021-12-31 CN¥1.87 Billion
≈ $273.22 Million
+9.52%
2020-12-31 CN¥1.70 Billion
≈ $249.46 Million
+154.88%
2019-12-31 CN¥668.86 Million
≈ $97.87 Million
+38.00%
2018-12-31 CN¥484.67 Million
≈ $70.92 Million
+31.55%
2017-12-31 CN¥368.42 Million
≈ $53.91 Million
-14.22%
2016-12-31 CN¥429.49 Million
≈ $62.85 Million
+24.39%
2015-12-31 CN¥345.28 Million
≈ $50.53 Million
+46.48%
2014-12-31 CN¥235.72 Million
≈ $34.49 Million
-17.93%
2013-12-31 CN¥287.22 Million
≈ $42.03 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Shanghai GenTech Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Comprehensive Income CN¥3.70 Billion 91.47%
Other Components CN¥344.99 Million 8.53%
Total Equity CN¥4.04 Billion 100.00%

Shanghai GenTech Co Ltd Competitors by Market Cap

The table below lists competitors of Shanghai GenTech Co Ltd ranked by their market capitalization.

Company Market Cap
Sitio Royalties Corp.
NYSE:STR
$1.41 Billion
Iluka Resources Limited
F:ILZ
$1.41 Billion
Genertec Universal Medical Group Company Limited
F:5UM
$1.41 Billion
Xiangtan Electrochemical Scientific Co Ltd
SHE:002125
$1.41 Billion
Shenzhen Sunline Tech Co Ltd
SHE:300348
$1.40 Billion
Anhui Hwasu Co.Ltd.
SHG:600935
$1.40 Billion
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
$1.40 Billion
Implenia AG
SW:IMPN
$1.40 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shanghai GenTech Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 3,451,490,737 to 4,043,933,000, a change of 592,442,263 (17.2%).
  • Net income of 137,984,300 contributed positively to equity growth.
  • Other comprehensive income increased equity by 3,515,581,698.
  • Other factors decreased equity by 3,061,123,735.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥137.98 Million +3.41%
Other Comprehensive Income CN¥3.52 Billion +86.93%
Other Changes CN¥-3.06 Billion -75.7%
Total Change CN¥- 17.16%

Book Value vs Market Value Analysis

This analysis compares Shanghai GenTech Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.32x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 13.94x to 2.32x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 CN¥2.34 CN¥32.66 x
2014-12-31 CN¥1.87 CN¥32.66 x
2015-12-31 CN¥1.91 CN¥32.66 x
2016-12-31 CN¥2.15 CN¥32.66 x
2017-12-31 CN¥2.33 CN¥32.66 x
2018-12-31 CN¥2.99 CN¥32.66 x
2019-12-31 CN¥3.63 CN¥32.66 x
2020-12-31 CN¥7.96 CN¥32.66 x
2021-12-31 CN¥7.20 CN¥32.66 x
2022-12-31 CN¥9.12 CN¥32.66 x
2023-12-31 CN¥10.70 CN¥32.66 x
2024-12-31 CN¥12.16 CN¥32.66 x
2025-12-31 CN¥14.07 CN¥32.66 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shanghai GenTech Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.41%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.80%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (3.41%) is below the historical average (8.42%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 -1.58% -2.01% 0.37x 2.12x CN¥-31.79 Million
2014 7.48% 3.29% 0.80x 2.84x CN¥-5.52 Million
2015 4.19% 2.43% 0.77x 2.24x CN¥-17.30 Million
2016 6.52% 3.61% 0.65x 2.77x CN¥-11.18 Million
2017 8.58% 4.32% 0.62x 3.20x CN¥-5.04 Million
2018 12.69% 6.52% 0.59x 3.29x CN¥12.74 Million
2019 12.41% 7.00% 0.70x 2.53x CN¥16.14 Million
2020 7.29% 11.20% 0.39x 1.66x CN¥-46.22 Million
2021 9.03% 9.17% 0.52x 1.88x CN¥-18.04 Million
2022 10.75% 9.57% 0.45x 2.47x CN¥17.98 Million
2023 13.37% 10.47% 0.48x 2.69x CN¥101.15 Million
2024 15.29% 9.65% 0.58x 2.71x CN¥182.60 Million
2025 3.41% 2.80% 0.00x 0.00x CN¥-266.41 Million

Industry Comparison

This section compares Shanghai GenTech Co Ltd's net assets metrics with peer companies in the Specialty Industrial Machinery industry.

Industry Context

  • Industry: Specialty Industrial Machinery
  • Average net assets among peers: $2,122,638,577
  • Average return on equity (ROE) among peers: 4.93%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shanghai GenTech Co Ltd (688596) CN¥3.92 Billion -1.58% 2.21x $1.41 Billion
Huayi Compressor Co Ltd (000404) $5.19 Billion 6.97% 1.68x $843.29 Million
Shenyang Machine Tool Co Ltd (000410) $709.50 Million 6.14% 1.68x $2.39 Billion
North Industries Group Red Arrow Co Ltd (000519) $7.53 Billion 1.67% 0.29x $3.61 Billion
Bingshan Refrigeration & Heat Transfer Technologies Co Ltd (000530) $2.71 Billion 4.79% 0.50x $520.37 Million
Changchai Co Ltd (000570) $1.86 Billion 2.98% 0.67x $522.04 Million
Jiangsu Youli Investment Holding Co Ltd (000584) $315.25 Million 5.68% 1.39x $32.29 Million
Baota Industry Co Ltd (000595) $436.15 Million 1.59% 1.56x $1.06 Billion
SUFA Technology Industry Co Ltd CNNC (000777) $969.93 Million 5.96% 0.61x $1.11 Billion
J.S. Corrugating Machinery Co Ltd (000821) $1.11 Billion 3.64% 0.40x $938.81 Million
Qinchuan Machine Tool & Tool Group Share Co Ltd (000837) $393.52 Million 9.87% 0.54x $1.66 Billion

About Shanghai GenTech Co Ltd

SHG:688596 China Specialty Industrial Machinery
Market Cap
$1.41 Billion
CN¥9.61 Billion CNY
Market Cap Rank
#7641 Global
#1868 in China
Share Price
CN¥32.66
Change (1 day)
+0.15%
52-Week Range
CN¥27.65 - CN¥48.74
All Time High
CN¥48.74
About

Shanghai GenTech Co., Ltd. provides process critical system solutions to customers in hi-tech and advanced manufacturing industries in China. The company offers equipment and system integration process services covering design, manufacturing and installation to hi-tech industries, including IC, flat panel displays, solar photovoltaics, LED, fiber optics, and bio-pharmaceutics. It also produces el… Read more